Optima Pharma will exhibit in Interpack 2023 (May 4-10, Düsseldorf) its portfolio of future-oriented technology, sophisticated processes and digital solutions for the pharmaceutical filling. Highlights his new Optima FillCell filling and closing system for cell and gene therapy.
Maximum efficiency and productivity are essential together with convincing answers in the areas of circular economy, resource conservation, digital technologies and product safety. “As a strategic partner, we are working together with our customers to address these challenges and develop the right solutions,” he says. Gerhard Breu, President of the Optima Pharma Division.
“We present a pioneering filling system for cell and gene therapeutic applications, as well as customized service solutions, and show our customers how to be a game changer when it comes to sustainability,” adds Breu.
Optima FillCell
The system can fill valuable cell and gene therapies with maximum product yield. This includes viral vectors in particular. Expensive drugs are seen as a beacon of hope in the fight against previously incurable diseases. A transport system without changeover parts provides flexible, gentle and safe handling.
Numerous digital features increase product and process safety, including, for example, camera systems for monitoring the inside of the machine and scanning systems for the safe change of format parts. This provides operators with optimal support and maximizes system availability.
As a turnkey provider, Optima Pharma offers systems like the Optima FillCell in combination with an isolator.
